AIDS Research and Treatment / 2014 / Article / Tab 1

Research Article

Engagement with Care, Substance Use, and Adherence to Therapy in HIV/AIDS

Table 1

Sample demographics.

Gender
 Male45559.2%
 Female29638.5%
 Transgender172.2%
Age42.8 yearsSD = 9.6 (range 20–72)
Race
 Asian/Pacific Islander111.4%
 African national and American/black33543.6%
 Hispanic/Latino21427.8%
 Native American Indian81.0%
 White/Anglo (non-Hispanic)16321.2%
 Other374.8%
Highest education
 Grade school22329.1%
 High school31841.5%
 Technical/vocational school14318.6%
 College597.7%
 Master’s202.6%
 Doctorate40.5%
# Children at home
 013937.9%
 18122.1%
 28021.8%
 3318.4%
 >4369.8%
Data Collection Sites
 USA (10)
  California (3)10713.8%
  Texas (3)19024.5%
  Massachusetts (1) 699.0%
  Utah (1) 699.0%
  Illinois (1) 162.0%
  Pennsylvania (1)10713.8%
 Africa (2)
  South Africa (1) 48 6.2%
  Kenya (1) 71 9.2%
 Puerto Rico (2)
  San Juan (1) 70 9.0%
  Vega Baja (1) 28 3.6%
AIDS diagnosis
 Yes32242.0%
 No40853.2%
 Don’t know 37 4.8%
Taking HIV Meds now
 Yes53770.4%
 No22629.6%
Other Medical Conditions
 Yes47062.7%
 No28037.3%
Years HIV Positive9.1 yearsSD ± 6.6 (Range: 0–26)
Recent CD4 Count (if known)407SD ± 268 (Range: 0–1200)
Viral Load “Undetectable”25133.4%
Viral Load (Greater than 50 copies/mL) ( )50368SD ± 135000 (Range: 50–750000)
Years on ARV Medications6.7 yearsSD ± 5.2 (Range: 0–20)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.